REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $844,283 | -87.7% | 73,609 | -72.8% | 0.00% | -83.3% |
Q2 2023 | $6,861,059 | -25.6% | 271,079 | -5.3% | 0.01% | -29.4% |
Q1 2023 | $9,216,956 | +190.5% | 286,151 | +66.5% | 0.02% | +142.9% |
Q4 2022 | $3,172,446 | -24.5% | 171,855 | +10.5% | 0.01% | -22.2% |
Q3 2022 | $4,201,000 | +319.7% | 155,567 | +113.2% | 0.01% | +350.0% |
Q2 2022 | $1,001,000 | -26.9% | 72,977 | +3.8% | 0.00% | -33.3% |
Q1 2022 | $1,369,000 | +15.3% | 70,281 | -3.6% | 0.00% | +50.0% |
Q4 2021 | $1,187,000 | -41.4% | 72,927 | +0.3% | 0.00% | -50.0% |
Q3 2021 | $2,027,000 | -10.3% | 72,703 | -4.6% | 0.00% | -20.0% |
Q2 2021 | $2,260,000 | -5.8% | 76,225 | -11.0% | 0.01% | -16.7% |
Q1 2021 | $2,398,000 | -9.9% | 85,642 | -8.7% | 0.01% | -14.3% |
Q4 2020 | $2,662,000 | -2.8% | 93,820 | -13.8% | 0.01% | -12.5% |
Q3 2020 | $2,739,000 | +5.8% | 108,841 | +2.7% | 0.01% | 0.0% |
Q2 2020 | $2,590,000 | +64.8% | 106,024 | -0.4% | 0.01% | +33.3% |
Q1 2020 | $1,572,000 | -13.0% | 106,431 | -4.5% | 0.01% | +20.0% |
Q4 2019 | $1,806,000 | – | 111,451 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |